Amyris

Amyris Long-term Debt

Delisted·May 7, 2024

The Long-Term Debt of Amyris (AMRSQ) as of Nov 21, 2026 is 772.24 M USD. In the previous year, Long-Term Debt was 309.06 M USD — a change of 149.87% (higher).

Long-term Debt

772.24 MUSD

YoY

149.87%

Last updated:

Long-Term Debt of Amyris is 2022 772.24 M USD. Long-Term Debt of Amyris was 2021 309.06 M USD. It decreases by 149.87% higher compared to the previous year.

The Amyris Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2015
115.90 M USD
Jan 1, 2016
168.20 M USD
Jan 1, 2017
107.00 M USD
Jan 1, 2018
62.20 M USD
Jan 1, 2019
197.97 M USD
Jan 1, 2020
185.62 M USD
Jan 1, 2021
309.06 M USD
Jan 1, 2022
772.24 M USD
The Amyris Long-term Debt history
YEARLong-term DebtYoY
772.24 MUSD+149.87%
309.06 MUSD+66.50%
185.62 MUSD-6.24%
197.97 MUSD+218.27%
62.20 MUSD-41.87%
107.00 MUSD-36.39%
168.20 MUSD+45.13%
115.90 MUSD-46.24%
215.60 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amyris Stock analysis

What does Amyris do? Amyris Inc. is a US-based company specializing in the production of sustainable products. It was founded in 2003 and is headquartered in Emeryville, California. The company aims to promote sustainability in daily life and reduce dependence on fossil fuels. Amyris' business model is based on the discovery and development of biological microorganisms capable of converting sugars and other carbohydrates into valuable products such as fuels, chemicals, and flavors. This technology, known as synthetic biology, was first used for the production of artemisinin, which is used against malaria. Over time, Amyris has expanded its portfolio and specialized in the production of sustainable products for the cosmetics, biofuel, food, and chemical industries. Leading products include Biosolve, an environmentally friendly degreasing solution for the industry, Neossance, a plant-based moisturizer for the cosmetics industry, and Biofene, a bio-based fuel. To produce its products, the company has formed partnerships with various organizations around the world. For example, it has partnered with Total, a French oil and gas company, to establish joint ventures for the production of biofuels. Amyris has also expanded its business by developing a platform for synthetic biology that allows other industry players to develop custom organisms for production processes. This new business model has brought the company into new markets such as the medical and energy sectors. In 2020, the COVID-19 pandemic posed challenges for the company as demand for some products declined. In response, Amyris shifted its production to disinfectants to meet the increased demand for these products. Overall, Amyris has become a leading company in sustainable production and is committed to promoting innovations in synthetic biology to have a positive impact on the environment. Amyris is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amyris stock

Long-Term Debt of Amyris is 772.24 M USD in 2022.

Long-Term Debt of Amyris changed from 309.06 M USD to 772.24 M USD, representing a 149.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt Amyris since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Amyris historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Amyris

All Key Metrics — Amyris